Spero Therapeutics (SPRO) Non-Current Debt (2019 - 2026)
Spero Therapeutics posted quarterly Non-Current Debt of $91000.0 for Q1 2026, little changed on a QoQ basis from $91000.0 in Q4 2025.
Spero Therapeutics (SPRO) has 8 years of Non-Current Debt data on file, last reported at $91000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt changed N/A year-over-year to $91000.0; the trailing twelve-month figure through Mar 2026 stood at $91000.0 (changed N/A YoY), and the FY2025 full-year result was $91000.0, changed N/A from the prior year.
- Non-Current Debt for Q1 2026 stood at $91000.0, roughly flat from $91000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $128000.0 in Q1 2022 and bottomed at $13000.0 in Q3 2024.
- The 5-year median for Non-Current Debt is $87000.0 (2023), against an average of $77846.2.
- The widest annual swing landed in 2023, when Non-Current Debt fell 9.38%; it then sank 79.03% in 2024.
- A 5-year view of Non-Current Debt shows it stood at $96000.0 in 2022, then dropped by 9.38% to $87000.0 in 2023, then tumbled by 85.06% to $13000.0 in 2024, then soared by 600.0% to $91000.0 in 2025, then changed by 0.0% to $91000.0 in 2026.
- The last three Non-Current Debt figures came in at $91000.0 (Q1 2026), $91000.0 (Q4 2025), and $13000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 105.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 91,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 85,000.00 |
| Mar 31, 2023 | 85,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Sep 30, 2022 | 107,000.00 |
| Sep 30, 2022 | 107,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Dec 31, 2021 | 138,000.00 |
| Dec 31, 2021 | 138,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 158,000.00 |
| Mar 31, 2021 | 168,000.00 |
| Mar 31, 2021 | 168,000.00 |
| Dec 31, 2020 | 177,000.00 |
| Dec 31, 2020 | 177,000.00 |
| Sep 30, 2020 | 186,000.00 |
| Sep 30, 2020 | 186,000.00 |
| Jun 30, 2020 | 196,000.00 |
| Jun 30, 2020 | 196,000.00 |
| Mar 31, 2020 | 205,000.00 |
| Mar 31, 2020 | 205,000.00 |
| Dec 31, 2019 | 249,000.00 |
| Dec 31, 2019 | 249,000.00 |
| Sep 30, 2019 | 256,000.00 |
| Sep 30, 2019 | 256,000.00 |
| Jun 30, 2019 | 293,000.00 |
| Jun 30, 2019 | 293,000.00 |
| Mar 31, 2019 | 312,000.00 |
| Mar 31, 2019 | 312,000.00 |